Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Endocrinology
Volume 2017, Article ID 3694868, 4 pages
Case Report

Hypocalciuric Hypercalcemia due to Impaired Renal Tubular Calcium Excretion in a Type 2 Diabetic Patient

1Department of Endocrinology and Metabolism, West China Hospital of Sichuan University, Chengdu, China
2Department of Chinese Traditional Medicine, The Second People’s Hospital of Yibin, Yibin, China

Correspondence should be addressed to Zhenmei An; moc.qq@343849848 and Tao Chen; moc.qq@oatnehc.rd

Received 17 November 2016; Accepted 9 January 2017; Published 11 April 2017

Academic Editor: Wayne V. Moore

Copyright © 2017 Sihao Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Bringhurst, M. Demay, and H. Kronenberg, “Hormones and disorders of mineral metabolism,” in Williams Textbook of Endocrinology, S. Melmed, K. Polonsky, P. Larsen, and H. Kronenberg, Eds., pp. 1260–1277, Elsevier Sauders, Philadelphia, Pa, USA, 12th edition, 2011. View at Google Scholar
  2. T. P. Jacobs and J. P. Bilezikian, “Clinical review: rare causes of hypercalcemia,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 11, pp. 6316–6322, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Lupica, M. Buemi, A. Campenni et al., “Unexpected hypercalcemia in a diabetic patient with kidney disease,” World Journal of Nephrology, vol. 4, no. 3, pp. 438–443, 2015. View at Publisher · View at Google Scholar
  4. P. Hardy, P. H. Morinière, B. Tribout et al., “Liver granulomatosis is not an exceptional cause of hypercalcemia with hypoparathyroidism in dialysis patients,” Journal of Nephrology, vol. 12, no. 6, pp. 398–403, 1999. View at Google Scholar · View at Scopus
  5. S. M. Hindi, Y. Wang, K. D. Jones et al., “A case of hypercalcemia and overexpression of CYP27B1 in skeletal muscle lesions in a patient with HIV infection after cosmetic injections with polymethylmethacrylate (PMMA) for wasting,” Calcified Tissue International, vol. 97, no. 6, pp. 634–639, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Makaya, S. Chatterjee, P. Arundel, C. Bevan, and N. P. Wright, “Severe hypercalcemia in diabetic ketoacidosis: a case report,” Diabetes Care, vol. 36, no. 4, article no. e44, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. D. V. Rados and T. W. Furlanetto, “An unexpected cause of severe and refractory PTH-independent hypercalcemia: case report and literature review,” Archives of endocrinology and metabolism, vol. 59, no. 3, pp. 277–280, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. J. C. Pallais, O. Kifor, Y.-B. Chen, D. Slovik, and E. M. Brown, “Acquired hypocalciuric hypercalcemia due to autoantibodies against the calcium-sensing receptor,” New England Journal of Medicine, vol. 351, no. 4, pp. 362–369, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Makita, J. Sato, K. Manaka et al., “An acquired hypocalciuric hypercalcemia autoantibody induces allosteric transition among active human Ca-sensing receptor conformations,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 13, pp. 5443–5448, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Guyton and J. Hall, “Renal regulation of potassium, calcium, phosphate, and magnesium; Integration of renal mechanisms for control of blood volume and extracellular fluid volume,” in Guyton and Hall Textbook of Medical Physiology, pp. 371–373, Elsevier Saunders, Philadelphia, Pa, USA, 12th edition, 2006. View at Google Scholar